Sagimet Biosciences Management
Management criteria checks 2/4
Sagimet Biosciences' CEO is Dave Happel, appointed in Oct 2022, has a tenure of 1.58 years. total yearly compensation is $2.69M, comprised of 18.7% salary and 81.3% bonuses, including company stock and options. directly owns 0.045% of the company’s shares, worth $61.88K. The average tenure of the management team and the board of directors is 1.3 years and 5.3 years respectively.
Key information
Dave Happel
Chief executive officer
US$2.7m
Total compensation
| CEO salary percentage | 18.7% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.04% |
| Management average tenure | 1.3yrs |
| Board average tenure | 5.3yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$503k | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$28m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$7m | US$98k | -US$30m |
Compensation vs Market: Dave's total compensation ($USD2.69M) is above average for companies of similar size in the US market ($USD663.07K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Happel (61 yo)
1.6yrs
Tenure
US$2,685,917
Compensation
Mr. David A. Happel, also known as Dave, has been Chief Executive Officer and Director of Sagimet Biosciences Inc. since October 2022 and serves as its President since October 2022. From March 2020 through...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 8.6yrs | US$930.22k | 0.018% $ 24.4k | |
| CEO, President & Director | 1.6yrs | US$2.69m | 0.045% $ 61.9k | |
| Chief Medical Officer | 3.3yrs | US$1.51m | 0% $ 0 | |
| Co-Founder | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Interim Principal Financial Officer & Interim Principal Accounting Officer | less than a year | no data | no data | |
| General Counsel & Chief Compliance Officer | 1.1yrs | no data | no data | |
| Senior Vice President of Research & Development | 1.3yrs | no data | no data |
1.3yrs
Average Tenure
60yo
Average Age
Experienced Management: SGMT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 8.6yrs | US$930.22k | 0.018% $ 24.4k | |
| CEO, President & Director | 1.6yrs | US$2.69m | 0.045% $ 61.9k | |
| Independent Director | 17.1yrs | US$14.38k | 0.41% $ 570.0k | |
| Independent Director | 3.1yrs | US$43.00k | 0% $ 0 | |
| Director | 5.3yrs | US$10.00k | 5.18% $ 7.2m | |
| Independent Director | 9.2yrs | US$45.00k | 0% $ 0 | |
| Independent Director | less than a year | no data | 0.0069% $ 9.5k | |
| Independent Director | 13.7yrs | US$41.50k | 0.040% $ 55.4k | |
| Independent Director | less than a year | no data | 0% $ 0 |
5.3yrs
Average Tenure
59yo
Average Age
Experienced Board: SGMT's board of directors are considered experienced (5.3 years average tenure).